| Pagets
Disease by drdoc on-line |
Definition Aetiology Epidemiology Clinical Investigations |
Differential
diagnosis Treatment Who should be treated Return to the arthritis pages of drdoc on-line |
|
| Go to top of page |
Pagets disease is a disease of the actual localized modelling of the bone architecture. Bone is a living
structure, and has many cells, but the main two, are the osteoclast
which resorbs bone and the osteoblast which lays down new quality bone.
These work in cycles - causing a process of new bone replacing old bone.
The calcification process - laying down of mineral calcium thereafter
proceeds and the bone hardens. The fundamental cause of this process is not known, but some evidence of a post viral phenomenon exists. Genetic components and family factors are also apparent. The disease was described by Sir James Paget in the 20th century, but is recognised in archeological specimens. The disease is more common as one gets older and is more common in males compared to females. It is unusual in black people compared to white people and is more commoner in the northern hemisphere (except Scandinavia). It occurs in 4-5% of most western countries after age 40, but in the 80's may be found in about 10% of people screened for Pagets - of whom the majority are not complaining of symptoms. The patient is frequently entirely assymptomatic and the condition can be discovered after routine Xrays, requested for other reasons. However of those people who become symptomatic, the commonest features are: Pain The sites of involvement
are most frequently, the lower limbs - tibia and femur, as well as
pelvis, skull, and spine. However - any bone can be involved. The site
of the process potentially causes aggravating circumstances and
complications. Involvement in the skull and spine can cause nerve
entrapment. ie deafness, or paralysis. Involvement around joints can
result in a secondary arthritis, and may result in cartilage damage.
Involvement of long bones causes deformity - with bending of the bones -
bowing. Deformity of the skull can occur with bony prominence - called
bossing. The circulation in the bone can be so extensive in some extreme
cases, that blood can be diverted from other organs or tissues - called
"steel" syndrome. Heart failure from increase in circulation,
or stroke or paralysis are rare such complications of this process. Transition of the process to a cancerous form is also well described. This is called sarcomatous transformation. This is associated with a change of symptoms and increase in pain. Vigilance may be required |
The condition is not an inflammatory one, but one of bone turnover and increased circulation. Therefore blood tests can be done to assess the state of bone turnover. The best single blood test is the alkaline phosphatase enzyme, which can also be used to follow the disease process and response to treatment. Xrays are also fairly classical in their appearence, although other conditions can mimic this. Various stges are seen..from an early lytic phase of bone washout ..to a mixed picture of bone disorganisation..to a later thickened and sclerotic picture with bone cysts. Technetium bone scan is very useful in assessing the whole body for distribution of the process. The biggest problem is
differentiation from malignancy, or spread from malignancy or change to
malignancy. Malignancy that can look like this include, lymphoma or
prostate malignancy. Since the problem of Pagets is common especially in
the elderly, co-existence of Pagets and malignancy may occur,
coincidently, making the clinical assessment even more complicated. The
transition to sarcoma, may be associated with a "sunburst"
appearence on the Xray. The disease is now treatable. Gone are the days where pain killers and antiinflammatories were the only approach. The mainstay of therapy at the current state of the art is that of bisphosphonates, either oral or intravenous pulse. Such preperations include - alendronate(oral), risedronate (oral) and pamidronate (intravenous). My personal preference is pamidronate, given as infusions of 30-60mg IV . Such therapy results in a reduction in the alkaline phosphatase, and reduction in pain. The infusion may last 12-18 months, but more frequent infusions can be given and dose increaded depending on response. Asymptomatic elderly
people do not require therapy, unless there are risks of complication -
especially if the disease interferes with adjacent joints. Symptomatic
disease should be treated. |
|
| Go to top of page | |||
| Go to top of page | |||
| Go to top of page | |||
| Go to top of page | |||
| Go to top of page | |||